1.
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
by Woodward, Mark
Heart (British Cardiac Society), 2007, Vol.93 (2), p.172-176

2.
Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects
by Muntner, Paul, PhD
The American heart journal, 2011, Vol.161 (4), p.719-725

3.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2

4.
Predictors of Low Clopidogrel Adherence Following Percutaneous Coronary Intervention
by Muntner, Paul, PhD
The American journal of cardiology, 2011, Vol.108 (6), p.822-827

5.
Effects of Prehypertension and Hypertension Subtype on Cardiovascular Disease in the Asia-Pacific Region
by Arima, Hisatomi
Hypertension (Dallas, Tex. 1979), 2012, Vol.59 (6), p.1118-1123

6.
Blood Pressure Indices and Cardiovascular Disease in the Asia Pacific Region: A Pooled Analysis
by Lawes, Carlene M M
Hypertension (Dallas, Tex. 1979), 2003, Vol.42 (1), p.69-75

7.
Blood Pressure Is a Major Risk Factor for Renal Death: An Analysis of 560 352 Participants From the Asia-Pacific Region
by OʼSeaghdha, Conall M
Hypertension (Dallas, Tex. 1979), 2009, Vol.54 (3), p.509-515

8.
Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease
by Campbell, Duncan J
Hypertension (Dallas, Tex. 1979), 2005, Vol.45 (1), p.69-74
